
This article reports the results of clinical testing in pediatric patients of a new contrast agent, zzso injection zzso developed by zzso zzso as a zzso zzso agent for use in magnetic resonance imaging zzso Thirteen children (four girls and nine zzso ranging in age from 10 to 18 years were enrolled in the zzso The children had MR studies of the brain and/or spine with zzso zzso and zzso injection zzso zzso Five children had primary brain or spine zzso three children had zzso disease to the central nervous system, one child had a zzso brain zzso and spinal canal zzso one child had an zzso zzso and two children were normal on the zzso zzso No minor or major reactions to zzso injection developed in the 13 zzso zzso injection provided excellent zzso and enhancement of the zzso zzso and all of the primary and secondary zzso of the central nervous system except for one case of a grade 1 zzso of the zzso zzso injection is a safe and excellent contrast agent for use in zzso 

